D3forME

Super Vitamin D is a health and nutrition startup founded in 2012 and headquartered in the United States. The company offers the D3forME topical supplement, which provides 4000 IU's of Vitamin D3 and is designed for individuals who struggle with maintaining a healthy level of Vitamin D through oral supplements. The product aims to address the high prevalence of Vitamin D deficiency, particularly in populations with difficulties in absorbing Vitamin D, such as cystic fibrosis patients, bariatric surgery patients, and geriatric patients. Additionally, it targets individuals who have compromised digestive tracts, making it difficult for them to digest oral Vitamin D supplements.

The D3forME supplement is positioned as a cost-comparable alternative to high-quality oral supplements, making it an attractive option for those seeking a more efficient and effective way to meet their Vitamin D needs. With over 50% of the population in the USA facing Vitamin D deficiency, the market potential for such a solution is considerable.

The last investment for Super Vitamin D amounted to $1.10M in a Venture Round on 15 September 2015. Although the specific investors for this round are not disclosed, this milestone signifies investor confidence in the company's mission and the potential of its innovative supplement. As the health care and nutrition industries continue to evolve, Super Vitamin D appears well-positioned to make a meaningful impact with its D3forME product offering.